Clin2
NCT06244069Possibly a fitNot yet recruiting

Study of clonal hematopoiesis in giant cell arteritis

Giant Cell ArteritisTemporal ArteritisClonal Hematopoiesis of Indeterminate PotentialHorton DiseaseSystemic Vasculitis Primary

Part of Brain & nervous system, Heart & circulation, Immune system & allergy, Skin clinical trials.

This study looks at whether people with suspected giant cell arteritis (a type of blood vessel inflammation) have a certain kind of blood cell change called clonal hematopoiesis. It aims to help doctors better understand the disease and could lead to improved care.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
326 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are believed to have active giant cell arteritis and are being quickly evaluated for it.
  • You are healthy and willing to be a match for comparison, OR you are a patient with suspected GCA.
  • You can have a biopsy of a small artery from your temple done within a few hours of joining the study.
  • You are not currently being treated for an active infection like tuberculosis, HIV, or hepatitis.
  • You have not taken immune-suppressing drugs or steroids (except low-dose steroids) in the recent weeks or months.
  • You do not have a serious ongoing health issue like active cancer, kidney failure, or advanced heart/lung disease.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06460142Recruiting
Biomarker study for giant cell arteritis and polymyalgia rheumatica

This study is looking for biomarkers (biological clues) in people with newly diagnosed or flaring giant cell arteritis (GCA) or polymyalgia rheumatica (PMR). Participating may help researchers find better ways to diagnose and monitor these conditions.

Bonn, North Rhine-Westphalia
NCT06279065Recruiting
Gut bacteria and giant cell arteritis study

This trial looks at how the bacteria in your gut might affect giant cell arteritis, a condition that causes inflammation in blood vessels. It aims to help doctors better understand the disease.

Bonn, North Rhine-Westphalia
NCT04474847Recruiting· Phase 3
Abatacept for giant cell arteritis treatment

This Phase 3 trial tests abatacept to treat giant cell arteritis (GCA), a blood vessel inflammation that can cause headaches and vision risk. It’s for people with newly diagnosed or returning (relapsing) GCA with active symptoms in the last 8 weeks.

Rochester, Minnesota
NCT05865054Recruiting
MRI check in early suspected giant cell arteritis

This trial tests how well a special MRI (picture scan) can evaluate giant cell arteritis when it’s newly suspected and symptoms started recently. It may help doctors confirm the diagnosis and decide on treatment sooner by comparing MRI findings with standard testing like biopsy or ultrasound.

Rochester, Minnesota
NCT02257866Recruiting
Study of blood vessel inflammation over time

This study looks at different types of blood vessel inflammation (vasculitis) to learn more about why they happen and how they progress. By joining, you may help doctors better understand these conditions and improve future treatments.

Bethesda, Maryland
NCT05854927Recruiting
MRI test for suspected giant cell arteritis

This study checks whether different MRI scanning details can better help doctors diagnose giant cell arteritis. If you’re being sent for an injected MRI because GCA is suspected, your scan results may help improve how future diagnoses are made.

Paris

Hear when a new Giant Cell Arteritis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.